LRCX Add to watchlist
$265.16 7.25 (-2.66%)
After Hours: $265.16 +0.00 (+0.00%)
Last updated: Apr 15, 2026 21:17
52-Week Range
$265.16
$61.14 $265.16 $273.50

Fundamentals Overview

Lam Research Corporation is near the high of its 52-week range with premium valuation, trending downward today.

Valuation premium

P/E 54 PEG 1.21 P/B 32.92 P/S 16.1

Intrinsic value (DCF)

-80.9% downside vs price

Profitability

Net margin 30.2%

Risk (Beta)

1.79 — higher vol

Earnings & growth

EPS $4.91 Rev +0.4% Profit +1.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 55% confidence Risk: High Volatility — Beta 1.79. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B · Sentiment improving (1 upgrade) · 3M vs S&P 500: +19.6% · 3M vs Technology sector: +17.9%

Pressures (Sell):

DCF 80.9% downside vs price · Beta 1.79 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$331.12B
P/E (TTM)
54.01
EPS (TTM)
$4.91
Dividend Yield
0.38%
52-Week Range
$61.14 - $273.50
Volume vs Avg
N/A
Beta
1.79

About

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. I...
Sector: Technology
Headquarters: US
Employees: 18,600
IPO Date: May 1984
Beta: 1.79 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 14, Equal Weight: 4, Outperform: 5, Overweight: 5, Positive: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $50.68; current price is $265.16. That’s a -80.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 54.01
DCF value (model) $50.68 (-80.9% vs price)
PEG (TTM) 1.21
P/B (TTM) 32.92
P/S (TTM) 16.1
P/FCF (TTM) 49.71
Liquidity & enterprise
Current Ratio (TTM) 2.26
Quick Ratio (TTM) 1.61
Cash Ratio (TTM) 0.99
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 30.22%
Gross margin (TTM) 49.8%
Operating margin (TTM) 33.76%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for LRCX.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 14Equal Weight 4Outperform 5Overweight 5Positive 2
1 upgrade, 0 downgrades
Price Target Consensus
Current $265.16
Median $280.00
Consensus $278.12
Low consensus $200.00
High consensus $350.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Susquehanna maintain Positive Positive 2026-04-09
Morgan Stanley maintain Equal Weight Equal Weight 2026-04-06
Barclays maintain Equal Weight Equal Weight 2026-03-10
Morgan Stanley maintain Equal Weight Equal Weight 2026-02-25
Goldman Sachs maintain Buy Buy 2026-01-29
Wells Fargo maintain Overweight Overweight 2026-01-29
Cantor Fitzgerald maintain Overweight Overweight 2026-01-29
UBS maintain Buy Buy 2026-01-29
RBC Capital maintain Outperform Outperform 2026-01-29
Morgan Stanley maintain Equal Weight Equal Weight 2026-01-29
Susquehanna maintain Positive Positive 2026-01-29
Needham maintain Buy Buy 2026-01-29
Stifel maintain Buy Buy 2026-01-29
Citigroup maintain Buy Buy 2026-01-29
Evercore ISI Group maintain Outperform Outperform 2026-01-29
JP Morgan maintain Overweight Overweight 2026-01-29
Citigroup maintain Buy Buy 2026-01-22
Deutsche Bank maintain Buy Buy 2026-01-21
Needham maintain Buy Buy 2026-01-20
UBS maintain Buy Buy 2026-01-20
Wells Fargo upgrade Equal Weight Overweight 2026-01-15
Stifel maintain Buy Buy 2026-01-14
B of A Securities maintain Buy Buy 2026-01-13
Bernstein maintain Outperform Outperform 2026-01-12
Mizuho maintain Outperform Outperform 2026-01-09
Cantor Fitzgerald maintain Overweight Overweight 2026-01-08
UBS maintain Buy Buy 2025-12-23
B. Riley Securities maintain Buy Buy 2025-12-18
Mizuho maintain Outperform Outperform 2025-12-17
Jefferies maintain Buy Buy 2025-12-15